600739.SH
辽宁成大
SSE · Healthcare · Medical - Distribution · CN
CNY 10.64
−0.19%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 9.4B | 9.9B | 10.8B | 10.3B | 14.1B |
| Cost of Revenue | 8.2B | 8.6B | 9.2B | 8.4B | 11.4B |
| Gross Profit | 1.3B | 1.3B | 1.5B | 1.9B | 2.7B |
| Operating Expenses | |||||
| R&D Expense | 294.4M | 294.0M | 282.9M | 220.5M | 211.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 516.9M | 497.1M | 459.4M | 493.5M | 485.9M |
| Selling & Marketing Expense | 546.8M | 563.5M | 616.8M | 584.7M | 592.0M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 2.0B | 2.0B | 2.0B | 1.9B | 1.9B |
| Cost and Expenses | 10.2B | 10.6B | 11.2B | 10.4B | 13.3B |
| Operating Income (EBIT) | 574.0M | 422.4M | 752.0M | 146.5M | 1.7B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 558.6M | 403.3M | 739.6M | 109.3M | 1.7B |
| Income Tax Expense | 64.0M | 73.5M | 75.4M | 121.5M | 260.1M |
| Bottom Line | |||||
| Net Income | 940.1M | 736.6M | 209.6M | 233.1M | 1.2B |
| Earnings from Cont. Ops | 494.5M | 329.9M | 664.2M | (12.2M) | 1.5B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 940.1M | 736.6M | 209.6M | 233.1M | 1.2B |
| Per Share | |||||
| Basic EPS | CN¥0.62 | CN¥0.48 | CN¥0.14 | CN¥0.15 | CN¥0.80 |
| Diluted EPS | CN¥0.62 | CN¥0.48 | CN¥0.14 | CN¥0.15 | CN¥0.80 |
| Revenue Per Share | CN¥6.16 | CN¥6.45 | CN¥7.20 | CN¥6.63 | CN¥9.21 |
| Shares | |||||
| Basic Shares Outstanding | 1.5B | 1.5B | 1.5B | 1.6B | 1.5B |
| Diluted Shares Outstanding | 1.5B | 1.5B | 1.5B | 1.6B | 1.5B |
| Profitability Metrics | |||||
| EBITDA | — | 780.5M | 1.1B | 497.8M | 2.1B |
| D&A | — | 358.1M | 363.6M | 351.3M | 374.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026